Tricyclic PI3K inhibitor compounds and methods of use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10435414
APP PUB NO 20180327420A1
SERIAL NO

16044862

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described herein are tricyclic compounds with phosphoinositide-3 kinase (PI3K) modulation activity or function having the Formula I structure:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GENENTECH, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Braun, Marie-Gabrielle San Francisco, US 14 28
Garland, Keira South San Francisco, US 4 3
Hanan, Emily South San Francisco, US 23 238
Heald, Robert Andrew Harlow Essex, GB 28 142
Knight, Jamie Harlow Essex, GB 12 36
Lu, Aijun Beijing, CN 14 11
Macleod, Calum Harlow Essex, GB 39 100
Purkey, Hans South San Francisco, US 3 11
Staben, Steven T San Francisco, US 10 27
Wu, Guosheng Beijing, CN 55 130
Yeap, Siew Kuen Harlow Essex, GB 4 11

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 8, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 8, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00